Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Bipolar & Cannabis Use Disorders
NCT03334721Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Oct 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in bipolar disorder (BD), cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Oct 2017; status: completed.
02
Drugs
gabapentin
03
Conditions
bipolar disorder (BD)cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT03334721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334721.